February 15, 2024 06:00 AM ESTUpdated 06:23 AM
Financing
Diagnostics

Freenome rais­es $254M for ear­ly can­cer de­tec­tion tests

Jared Whitlock

Features Editor

Freenome has raised an ad­di­tion­al $254 mil­lion in pri­vate fund­ing, led by Roche, as the com­pa­ny nears piv­otal re­sults for its blood-based can­cer test. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times